Apellis Pharmaceuticals, Inc. financial data

Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Fifth Avenue, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 433 % -5.24%
Quick Ratio 67.9 % +16.8%
Debt-to-equity 254 % +29.6%
Return On Equity -79.4 % +55.5%
Return On Assets -22.5 % +62.8%
Operating Margin -21.1 % +83.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126M shares +3.42%
Common Stock, Shares, Outstanding 124M shares +4.13%
Entity Public Float 4.2B USD -60.7%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 124M shares +4.4%
Weighted Average Number of Shares Outstanding, Diluted 124M shares +4.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 781M USD +97%
Research and Development Expense 328M USD -7.57%
General and Administrative Expense 501M USD +80.7%
Operating Income (Loss) -165M USD +68.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -197M USD +62.6%
Income Tax Expense (Benefit) 1.16M USD -45.5%
Net Income (Loss) Attributable to Parent -198M USD +62.6%
Earnings Per Share, Basic -1.6 USD/shares +64%
Earnings Per Share, Diluted -1.6 USD/shares +64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 411M USD +17.1%
Accounts Receivable, after Allowance for Credit Loss, Current 265M USD +28.3%
Inventory, Net 81.4M USD -44.4%
Other Assets, Current 11.6M USD -48%
Assets, Current 789M USD +2.95%
Property, Plant and Equipment, Net 2.95M USD -32.1%
Operating Lease, Right-of-Use Asset 16.1M USD -3.95%
Other Assets, Noncurrent 1.35M USD +3.06%
Assets 885M USD +12.2%
Accounts Payable, Current 38.6M USD +2.82%
Accrued Liabilities, Current 140M USD +9.69%
Liabilities, Current 186M USD -25.1%
Operating Lease, Liability, Noncurrent 10.2M USD -10.9%
Other Liabilities, Noncurrent 7.97M USD +245%
Liabilities 657M USD +10.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.31M USD +6.61%
Retained Earnings (Accumulated Deficit) -3.04B USD -6.97%
Stockholders' Equity Attributable to Parent 229M USD +17.5%
Liabilities and Equity 885M USD +12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -133M USD +25.1%
Net Cash Provided by (Used in) Financing Activities 108M USD -72.3%
Net Cash Provided by (Used in) Investing Activities -293K USD -13.1%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 124M shares +4.13%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -25.3M USD -112%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 413M USD +17.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.64M USD 0%
Deferred Tax Assets, Valuation Allowance 724M USD -3.96%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 726M USD -3.92%
Operating Lease, Liability 17M USD -5.26%
Depreciation 444K USD +5.46%
Payments to Acquire Property, Plant, and Equipment 293K USD +13.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -198M USD +62.8%
Lessee, Operating Lease, Liability, to be Paid 18.3M USD -7.49%
Operating Lease, Liability, Current 6.75M USD +4.84%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.08M USD +13.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.47M USD +1.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -13.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.35M USD -28.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.35M USD -55.6%
Deferred Tax Assets, Operating Loss Carryforwards 313M USD -5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 559K USD -34.9%
Operating Lease, Payments 2.31M USD +14.3%
Additional Paid in Capital 3.27B USD +7.63%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%